Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Age‐ and Sex‐Adjusted Body Mass Index Increases in Childhood Acute Lymphoblastic Leukaemia Patients From Diagnosis to Five‐Year Follow‐Up

Kytömäki, Aino; Huurre, Anu; Lähteenmäki, Päivi M.; Vahlberg, Tero; Järvelä, Liisa S.

Age‐ and Sex‐Adjusted Body Mass Index Increases in Childhood Acute Lymphoblastic Leukaemia Patients From Diagnosis to Five‐Year Follow‐Up

Kytömäki, Aino
Huurre, Anu
Lähteenmäki, Päivi M.
Vahlberg, Tero
Järvelä, Liisa S.
Katso/Avaa
Acta Paediatrica - 2025 - Kytömäki - Age‐ and Sex‐Adjusted Body Mass Index Increases in Childhood Acute Lymphoblastic.pdf (422.6Kb)
Lataukset: 

Wiley
doi:10.1111/apa.70413
URI
https://doi.org/10.1111/apa.70413
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe202601216670
Tiivistelmä

Aim

Children with acute lymphoblastic leukaemia (ALL) are at risk of metabolic and cardiovascular complications. We evaluated the development of overweight and obesity for 5 years after diagnosis in children and adolescents treated for ALL.

Methods

The medical records of children diagnosed with ALL at one centre during 2000–2018 were assessed. Weight and height measurements were retrieved from medical records and were used to calculate age- and sex-adjusted International Obesity Task Force-Body Mass Index (ISO-BMI). ISO-BMI was determined at selected time points during treatment and up to 5 years after diagnosis, and the change in mean ISO-BMI was assessed.

Results

We studied 115 patients diagnosed with ALL, 54 (47%) of whom were male. Mean age at diagnosis was 6.6 ± 4.6 (range 0–17.99) years. ISO-BMI increased significantly during treatment (p < 0.0001) and remained elevated at 5 years after diagnosis (p < 0.0001). The number of overweight and obese patients increased from 17% and 4% at diagnosis to 26% and 16% at the five-year follow-up.

Conclusions

Patients treated for ALL are at significant risk of weight gain and obesity, with the prevalence of overweight and obesity doubling from diagnosis to 5 years post-treatment. ISO-BMI remained persistently elevated across all treatment risk groups.

Summary


  • Children and adolescents with acute lymphoblastic leukaemia (ALL) are at risk of metabolic and cardiovascular late effects.
  • The number of overweight and obese subjects doubled from ALL diagnosis to five-year follow-up, with over 40% of children and adolescents being overweight or obese at 5 years after diagnosis.
  • Excess weight gain during ALL treatment affected all the treatment risk groups, so effective ways to intervene are needed.
Kokoelmat
  • Rinnakkaistallenteet [29337]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste